Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Revenue (2020 - 2025)

Pliant Therapeutics (PLRX) has disclosed Revenue for 5 consecutive years, with -$136000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Revenue changed N/A to -$136000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.6 million, a N/A change, with the full-year FY2023 number at $1.6 million, down 83.69% from a year prior.
  • Revenue was -$136000.0 for Q4 2025 at Pliant Therapeutics, up from -$815000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $5.0 million in Q2 2022 to a low of -$815000.0 in Q3 2025.
  • A 4-year average of $1.2 million and a median of $1.4 million in 2022 define the central range for Revenue.
  • Peak YoY movement for Revenue: surged 178.87% in 2022, then crashed 95.03% in 2023.
  • Pliant Therapeutics' Revenue stood at $2.0 million in 2021, then decreased by 1.7% to $2.0 million in 2022, then tumbled by 87.38% to $248000.0 in 2023, then crashed by 154.84% to -$136000.0 in 2025.
  • Per Business Quant, the three most recent readings for PLRX's Revenue are -$136000.0 (Q4 2025), -$815000.0 (Q3 2025), and -$809000.0 (Q2 2025).